Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders

Masakatsu Nakamura; Toshimi Otsuka; Motona Kumagai; Tomiyasu Arisawa

doi:10.2169/internalmedicine.7725-21

Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders

Masakatsu Nakamura, Toshimi Otsuka, Motona Kumagai, Tomiyasu Arisawa

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	267-269
Number of pages	3
Journal	Internal Medicine
Volume	61
Issue number	2
DOIs	https://doi.org/10.2169/internalmedicine.7725-21
Publication status	Published - 2022
Externally published	Yes

All Science Journal Classification (ASJC) codes

Internal Medicine

Access to Document

10.2169/internalmedicine.7725-21

Cite this

@article{18149568de0c4e1ea8f07060a551f1ae,

title = "Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders",

author = "Masakatsu Nakamura and Toshimi Otsuka and Motona Kumagai and Tomiyasu Arisawa",

year = "2022",

doi = "10.2169/internalmedicine.7725-21",

language = "English",

volume = "61",

pages = "267--269",

journal = "Internal Medicine",

issn = "0918-2918",

publisher = "Japanese Society of Internal Medicine",

number = "2",

}

TY - JOUR

T1 - Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders

AU - Nakamura, Masakatsu

AU - Otsuka, Toshimi

AU - Kumagai, Motona

AU - Arisawa, Tomiyasu

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85122958395&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85122958395&partnerID=8YFLogxK

U2 - 10.2169/internalmedicine.7725-21

DO - 10.2169/internalmedicine.7725-21

M3 - Article

C2 - 34248122

AN - SCOPUS:85122958395

SN - 0918-2918

VL - 61

SP - 267

EP - 269

JO - Internal Medicine

JF - Internal Medicine

IS - 2

ER -

Pembrolizumab-induced Eosinophilic Gastrointestinal Disorders

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this